Jim McCamant
Jim McCamant
ahead almost difficult fda gotten problem
I think it's probably almost 50-50 the FDA says, 'go ahead and give us the documentation for filing,' ... The problem is that historically the FDA's always gotten more difficult in these cases.
clinical favor finally gene later point products stage therapy
Gene therapy has been out of favor but we're finally getting to the point where the products are in later stage clinical trials.
clinical risks seen
There's always risks when you haven't seen the clinical data.
competition market products time
There will be a lot of competition out there by the time these products get to market -- if they do.
ahead larger love
They would love to have the colorectal go ahead because that's a larger market,
stocks window
The IPO window for biotech stocks is closing.